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The purpose of this study was to examine the incidence of patients with NES vs. NES and concomitant epilepsy in an epilepsy
centre and to present a diagnostic algorithm. We collected and reviewed the data of 322 patients consecutively referred to the
adult ward of our epilepsy centre in 1 year. The results of our study reveal that 44 (14%) of all patients referred had NES. Of
these, nine proved to have concomitant epilepsy. Of 44 patients with NES, 20 were treated with AED on admission. In 14 cases
this unnecessary antiepileptic drug treatment was stopped. In six remaining patients with NES and concomitant epilepsy, the
total number of AEDs could be reduced until discharge. The maximum duration of AED treatment among patients with NES
only, had been longer than 360 months (median 72 months).
Much has been written about whether the diagnosis of psychogenic non-epileptic events is overused. According to our
experience however, the fact that many patients with so-called ‘pharmacoresistant epilepsy’, suspected NES or other diagnoses
are referred to a centre of excellence much too late, proves to be the key problem in diagnosis and treatment of NES.
We conclude that early admission of so-called ‘pharmacoresistant epilepsy’ to an epilepsy centre, establishing a standard
work-up and clarifying the medical terminology will improve diagnosis and lead to adequate therapy of NES as well as prevent
unnecessary drug treatment.
c© 2002 BEA Trading Ltd. Published by Elsevier Science Ltd. All rights reserved
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INTRODUCTION
The issue of NES has been problematic1. An
estimated prevalence of psychogenic non-epileptic
seizures between 1/50 000 and 1/30002 making it a
significant neurological condition. Having been con-
fronted with relatively high numbers of patients with
so-called ‘pharmacoresistant epilepsy’ or suspected
NES in preceding years, who had been referred
to our epilepsy centre rather late, we decided to
study the incidence of patients with ‘non-epileptic
seizures’ (NES) vs. NES and concomitant epilepsy.
Furthermore we examined the consequences of late
referral, especially in terms of amount and duration of
unnecessary antiepileptic drug (AED) treatment.
Among the existing variety of more than 15
different synonyms3 we favour the term ‘non-
epileptic seizures’ for the same reasons discussed by
Irwin et al.4 and Scull3 and Betts5. Although the
terms ‘pseudoseizure’ or ‘pseudoepileptic seizure’ are
commonly used, we agree with Scull3 and Betts5 that
their great weakness consists in being unacceptable
to patients as well as to their families; these terms
tend to imply that the seizures are somewhat ‘unreal’.
Besides, terms with the prefix ‘pseudo’ tend to
have a pejorative meaning. NES is a term that is
non-judgemental, acceptable to patients and serving
descriptive and neutral patterns at the same time.
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METHODS
All patients referred to the adult ward of our clinic
during the period January 1997 to December 1997
were included. These patients underwent internal, neu-
rological and psychiatric examination. The means of
our work-up and diagnosis were: clinical observation
on the ward, review of patient charts and history, the
time span since/age at seizure onset, drug history and
additional psychiatric, psychosomatic or other disease
in the history of these patients, potential etiology
for epilepsy; we also checked family and state of
partnership, number of children and job situation.
All patients underwent a 20-minute-EEG recor-
ding and if necessary (see algorithm: Fig. 1)
non-invasive video-EEG-observation with electrodes
placed according to the 10-10 system. The EEG-data
was analyzed on a digital system using in-house soft-
ware (Brainstar). Anti-epileptic drugs were reduced
during video-EEG-observation to provoque seizures
as part of our standard-work-up for long-term video-
EEG-recordings (compare 6, 7). All recorded events
were pre-analyzed by two board-certified electroen-
cephalographers (M.M., Ch.D., both German board)
experienced in the field of epilepsy surgery and
the work-up of long-term video-EEG-recordings and
finally re-analyzed by the whole team including
one additional board-certified electroencephalogra-
pher (H.-J.M., German board). The final diagnosis of
NES was decided upon only if all electroencephalo-
graphers agreed on the diagnosis independently and
consistently for the recorded events in each patient.
The diagnosis of NES alone was used only, if no other
seizure type was recorded and if there was no history
of any other seizure types in this patient. This was
counter-checked through presentation of the recorded
events to family and/or partner to see whether the
recorded events are the ones in question (the ones
the patient was treated for in the past). If any other
type of events was reported in the history of the
patient, the video-EEG work-up has been extended
in duration or repeated either until all reported types
of events were recorded, or the patient was identified
as showing NES and (eventual) earlier concomitant
epilepsy (based on the given history data) without
ongoing epileptic seizures that would require any
further AED treatment. Patients whose AED treatment
was ceased were followed-up for at least 6 months.
If during this time-span any other new seizure type
occurred, which was not already diagnosed as NES,
the evaluation was once more repeated to investigate
if epileptic seizure in this patient had recurred.
RESULTS
In the period under analysis 322 patients were
admitted to the adult ward of our epilepsy centre
within 12 months. The number of patients with non-
epileptic seizures (one patient actually had epileptic
seizures following alcohol withdrawal, but no diag-
nosis of epilepsy) was 13.6% of all referred patients
(44 patients out of a total of 322 patients). Nine of
these 44 patients (2.8%) also had concomitant epilepsy
or a history of epileptic seizures [three patients;
convincing description of Grand Mal in the history
but without ongoing epileptic seizures which would
require any further antiepileptic drug treatment for the
time being (see Fig. 2)]. The age distribution of the
investigated group of patients with NES ranged from a
minimum of 16 years to a maximum of 68 years of age
(median: 35 years). The gender differentiation of our
study shows a NES-predominance of 23 for the female
sex (29 females, 15 males; see Table 1). A total of
24 (54%) out of the 44 NES-patients had a diagnosis of
epilepsy on admission. As shown in Table 2, 17 (38%)
patients out of the 44 patients with NES could be
diagnosed having paroxysmal events of organic origin
(organic NES).
A break down of reasons for referral to our epilepsy
centre in all 44 patients revealed that admission
of 23 patients had been initiated for differential
diagnosis/syndrome diagnosis while in eight patients
optimization of drug therapy was requested; in
five patients long-term video-EEG-analysis due to
suspicion of psychogenic NES has been the reason
for referral.
Table 1:
Gender and age distribution of patients with NES (N = 44)
Male Female
Sex 15 29
Min Max Min Max
Age distribution 21 44 16 68
Table 2:
Pat. with organic NESa—analysis of diagnoses Total: 17
Syncopes 7
Migraine or tension headaches 4
TIAs 2
Benign myoclonia 1
Myasthenia gravis 1
Paroxysmal choreoathethosis 1
ES due to alcohol abusea 1
a Pat. with ES (epileptic seizures) due to alcohol withdrawal, but
no diagnosis of epilepsy.
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Diagnostic Algorithm in patients with suspected NES
Diagnosis Epilepsy ruled out
(e.g.: Syncopes; Migraine;
Myasthenia gravis; Alcohol
withdrawal seizures etc.)
Long-Term-Video-EEG (min. 24hrs.; including
awake and sleep stages and drug reduction)
if no definite diagnosis possible at this moment
3rd Long-Term-Video-EEG (min. 24hrs.;
consider placebo Induction test at this moment)
if no definite diagnosis possible at this moment
if no definite diagnosis possible at this moment
(no EEG-seizure; no post-ictal changes on the
EEG, but obscured EEG)
2nd Long-Term-Video-EEG (min. 24hrs.; including
awake and sleep stages and drug reduction)
History (AED-history;
 family-history;
description of
 seizure semiology)
Laboratory and other test-
 results (e.g.:
 Schellong-test;
24 hrs.-ECG;
 24 hrs.-RR)
Routine-EE  (including 5 Min.
  overbreathing
 and
  photostimulation)
 ___________________________ 
Diagnosis Epilepsy confirmed
(e.g.: definite epileptic seizure
observed on the ward - no other
seizure types reported; ictal EEG
during routine-EEG-recording
etc.)
Diagnosis of NES confirmed
(all recorded events are
diagnosed to be NES and are
consistent with all the events
described in the history of the
patient).             OR:
Fig. 1:
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total of all patients referred: 322
total of all patients with NES: 44
(this equals 13,6 %)
number of patients with NES 
and concomitant epilepsy: 9
(this equals 2,8 %)
Fig. 2:
Before referral and diagnosis, 20 of 44 NES
patients already had been treated with antiepileptic
drugs (AEDs). A considerable number (14/44) of
patients turning out to have NES alone had already
been treated with AEDs for some months or even
decades. The maximum duration of AED treatment
among all patients with NES had been longer than
360 months, the median duration of such treatment
was 132 months. The median duration of AED
treatment in patients with NES alone was 72 months
(see Table 3). The age of onset of NES in these patients
ranged from age 12 (minimum) to age 64 (maximum),
with a median of 25 years of age at onset. In six
patients with NES and concomitant epilepsy we were
able to trace the age of onset for the epileptic seizures
as well as for the non-epileptic seizures from the
patient’s history. In all of these patients the NES
started years later than the epileptic seizures; in three
cases more than 15 years later (see Table 4).
As a result of the diagnostic procedure described
above we were able to stop AED treatment in 14 out
of the 20 patients mentioned above who have already
been treated with AEDs. Furthermore, the total num-
ber of AEDs applicated in the six patients (out of nine)
with NES and concomitant epilepsy, who still needed
AEDs, could be reduced from a total of 12 AEDs to
only seven AEDs; so five patients were successfully
switched to a monotherapy. These patients had been
unnecessarily treated with multiple AEDs against
the seemingly ‘pharmacoresistant epileptic seizures’
before our work-up, which in fact were NES (see
Fig. 3).
Table 3:
Duration of AED treatment Duration of AED treatment
in all patients in patients with
with NES (in months) NES alone
Min. 2 2
Median 132 72
Max. >360 >360
Mean 121.1 104.2
Table 4:
Age of onset of the epileptic seizures compared to the
age at onset of the non-epileptic seizures in six patients
with concomitant epilepsy
Patient Age at onset of the Age at onset of the
No. epileptic seizures non-epileptic seizures
1 1 23
2 25 40
3 29 37
4 31 33
5 31 36
6 36 55
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number of AEDs in the 6 patients
with ongoing concomitant epilepsy
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7
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Fig. 3:
In these three patients who were diagnosed as
having NES while examined in this study, and without
epileptic seizures being detected now, but with a
convincing history of epileptic seizures in the past,
we were able to reduce the AED treatment to zero.
Epileptic seizures did not reoccur (follow-up time span
>6 months).
DISCUSSION
Our study shows lower ratios for NES in patients
with pharmaco-resistant seizures than the results of
previous studies; the ratio of non-epileptic seizures in
patients with ‘intractable epilepsy in these studies is
reported to be as high as 20–25%10–15. King et al.
12 in their study found a total of 16 patients with
‘pseudoseizures’ in 60 patients having completed
the protocol. A video-EEG proof has been asked
for; cases of inadequate video, uninterpretable EEG
or uncertainty despite adequate quality have been
excluded. Gates et al. reported that in a 2-year period
at the Epilepsy Treatment Unit of the Minnesota
Comprehensive Epilepsy Program ‘20% of patients
with intractable seizures had pseudoseizures’13.
The results of our study show lower numbers, but are
in line with those of other more recent studies8, 9. In
comparison to Dodrill and Holmes (inclusion criteria:
all patients referred to the Epilepsy Centre with
‘intractable epilepsy’; n = 369 patients; patients with
NES alone = 14.8%; patients with both epileptic and
nonepileptic seizures = 3.6%) our ratios of patients
having NES, out of all patients (13.6%) and of patients
having epilepsy and nonepileptic events (2.8%) are
nearly concordant. Boon et al.16 found NES in 8%
of all their 400 patients who were monitored at their
Epilepsy Monitoring Unit, but of course one has
to bear in mind, that this patient group is already
more selected than in our study and the other studies
mentioned above. In line with Dodrill and Holmes
we conclude that diagnostic improvement will reduce
the number of patients being treated inadequately. In
Dodrill and Holmes’ study a high number of NES
patients have been treated with AEDs due to the wrong
diagnosis of epilepsy prior to admission (74 out of
88 patients with NES)8. Bracht et al.9 diagnosed
NES in 25 out of 51 patients (equals 49%) who
had been incorrectly diagnosed with epilepsy. In their
study 88% of the patients with NES alone were taking
AEDs. Both these figures are comparable to ours.
The female predominance (66%) we found con-
cerning the gender distribution meets a tendency
already reported: Bracht et al.9 reported a female
predominance of 78.5% and Lesser17 of 75%.
Concerning the diagnostic algorithm it has been
mentioned in other studies that video-EEG and clinical
observation as well as a close review of the general
medical and drug history must be considered as
a minimal diagnostic standard, especially in the
group of therapy–refractory patients6, 17. Video-EEG
monitoring remains the method of choice for seizure
classification in this situation9.
In contrast to Sakamoto et al.18 our work-up algo-
rithm does not include induction tests (e.g. placebo
infusion) during the second round of a long-term
video-EEG-recording. In 1997 we only performed one
induction test (at the end of 10 days of permanent
video-EEG-recording) in a patient with suspected
NES. In this patient the induction test was followed
by a Grand mal. This stresses the fact that induction
tests can also induce epileptic seizures in the form
of psychogenic epileptic seizures19, 20, or even can
cause psychogenic non-epileptic seizures in patients
who might not have had psychogenic NES before, and
we therefore could encounter additional problems—
the personal consequences for these patients not
yet mentioned.
Concerning this and other diagnostic tools we
furthermore doubt whether they are ethically ade-
quate or technically practicable: among these are
seizure provocation with invasive methods, suggestive
techniques and placebo operations21, especially for
Fenwick’s argument of the aspect of patient devaluing
in placebo technique and the impossibility to meet
informed consent with this method22.
CONCLUSION
Until now, there is no diagnostic standard for
suspected psychogenic NES23, although different
authors mentioned minimum standards as routine-
EEG or long-term video-EEG-recordings8, 16, 18, 21.
We argue that a patient history of assumed
‘pharmacoresistant seizures’, including therapy with
two major and established AEDs not having shown
success (i.e. patient being seizure free) within a
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maximum time span of 2 years of treatment, should
lead to a thorough new evaluation. Admission of these
patients to an epilepsy centre, which is also taking part
in an epilepsy–surgery program additionally opens up
the possibility of a skilled review of the diagnosis
and differentiation between true pharmacoresistant
epilepsies of which a considerable number of focal
types can be treated surgically, and other organic NES
or psychogenic NES. In the latter cases the patients
will profit from early diagnosis as it will prevent
unnecessary AED treatment in patients with NES
alone or AED combinations in patients with NES and
concomitant epilepsy. The patients with NES will also
profit from an earlier psychotherapeutic intervention
and treatment instead23.
It has to be mentioned that surface routine-EEG is
not a gold standard, nor does clinical history alone
provide enough information for reliable differenti-
ation between epileptic seizures and non-epileptic
seizures9. Long-term video-EEG analysis performed
under supervision of trained electrophysiologists
is explicitly necessary in patients whose EEG—
combined with bizarre seizure patterns—is full of
artefacts. Such analyses need skills, which in our
opinion can only be guaranteed by referral to a ‘centre
of excellence’, specialized in epilepsy.
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